See All Slides - tctmd.com

Slides

Presentation ACC 2012

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

Presenter: Gennaro Sardella

March 24, 2012

Presentation PCI Outcomes 2012

Controversy 3: In an Era of Increasing Governmental and Payer Oversight, Who Is Appropriate (and Not Appropriate) for PCI?

Presenter: Manesh R. Patel

March 23, 2012

Presentation PCI Outcomes 2012

Controversy 2, Part B: The Case for PCI in Patients with Complex Coronary Artery Disease

Presenter: Antonio Colombo

March 23, 2012

Presentation PCI Outcomes 2012

Optimizing Stent Selection (A Patient- and Lesion-Specific Approach)

Presenter: Martin B. Leon

March 23, 2012

Presentation PCI Outcomes 2012

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Presenter: C. Michael Gibson

March 23, 2012

Presentation PCI Outcomes 2012

Hemodynamic Support: In Whom, When, and Which

Presenter: Jeffrey J. Popma

March 23, 2012

Presentation PCI Outcomes 2012

Prevention and Treatment of Stent Thrombosis

Presenter: Ajay J. Kirtane

March 23, 2012

Presentation PCI Outcomes 2012

My Fellow's Worst Complication

Presenter: Paul S. Teirstein

March 23, 2012

Presentation PCI Outcomes 2012

Case 1: Multivessel PCI: Justification and Outcomes

Presenter: Frederick Feit

March 23, 2012

Presentation PCI Outcomes 2012

Optimizing Pharmacology Before, During and After PCI

Presenter: E. Magnus Ohman

March 23, 2012

Advertisement

Slides

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

Controversy 3: In an Era of Increasing Governmental and Payer Oversight, Who Is Appropriate (and Not Appropriate) for PCI?

Controversy 2, Part B: The Case for PCI in Patients with Complex Coronary Artery Disease

Optimizing Stent Selection (A Patient- and Lesion-Specific Approach)

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Hemodynamic Support: In Whom, When, and Which

Prevention and Treatment of Stent Thrombosis

My Fellow's Worst Complication

Case 1: Multivessel PCI: Justification and Outcomes

Optimizing Pharmacology Before, During and After PCI

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content